Chemomab Therapeutics Ltd
NASDAQ:CMMB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Chemomab Therapeutics Ltd
NASDAQ:CMMB
|
IL |
|
Vitesco Technologies Group AG
F:VTS
|
DE |
|
C
|
Cal-Maine Foods Inc
F:CM2
|
US |
|
P
|
Public Storage
F:PUP
|
US |
|
Siltronic AG
OTC:SSLLF
|
DE |
|
V
|
Vita 34 AG
DUS:V3V
|
DE |
|
G
|
Grupo Aeroportuario del Centro Norte SAB de CV
XMUN:G7A
|
MX |
|
E
|
Eli Lilly and Co
XBER:LLY
|
US |
|
S
|
Securitas AB
XMUN:S7MB
|
SE |
|
C
|
Credit Suisse Group AG
XBER:CSX
|
CH |
|
R
|
Ross Stores Inc
XMUN:RSO
|
US |
|
E
|
Eastgroup Properties Inc
F:EGO
|
US |
|
Triller Group Inc
OTC:ILLR
|
US |
|
A
|
argenx SE
SWB:1AE
|
NL |
Bankruptcy Probability
Chemomab Therapeutics Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Chemomab Therapeutics Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| IL |
|
Chemomab Therapeutics Ltd
NASDAQ:CMMB
|
12.5m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
438.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
196.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
161.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
123.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
70.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
47.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Chemomab Therapeutics Ltd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Chemomab Therapeutics Ltd has no debt.
You can find a full breakdown on its Balance Sheet.
